IRB #

STUDY00015164

Title

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Principal Investigator

Arpana Naik

Study Purpose

The purpose of this study is to determine if radiation to lymph nodes after chemotherapy is inferior to dissection of lymph nodes after chemotherapy.

Medical Condition(s)

Breast cancer

Eligibility Criteria

18+ years of age, undergone chemotherapy, cancer-positive lymph nodes identified during surgery or at final pathology, no other cancer within 5 years, not pregnant or nursing.

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

5-6 years

Minors Included

No

Contact

John Minger
Sr. Research Assistant
Oregon Health & Science University
Department of Radiation Medicine
503-494-8756

Sponsor

Alliance for Clinical Trials in Oncology

Recruitment End

12/31/2018

Compensation Provided

No


Go Back